GLP-1 Receptor Agonists: A Game-Changer for Kidney Disease Patients

Learn how GLP-1 receptor agonists, originally developed for diabetes, are changing the game in managing chronic kidney disease. In this episode, Dr. Bismah Irfan, MD, shares real-world evidence and insights on how these medications go beyond blood sugar control to protect the kidneys, support weight loss, and reduce cardiovascular risks. Tune in to stay ahead of the curve in kidney health.

Dr. Bismah Irfan, MD, is a board-certified nephrologist who brings a functional medicine approach to kidney care. In this episode, I explore how GLP-1 receptor agonists—originally used to control blood sugar—are proving to be powerful tools in protecting kidney health.

From real-world stories to research-backed insights, I’ll demonstrate how these medications can support individuals with chronic kidney disease, diabetes, and other associated risk factors.

Whether you’re managing CKD or exploring new ways to protect your health, this episode offers actionable insights rooted in science and clinical practice.

Connect with the host

Facebook:https://www.facebook.com/KidneyHealthMD

Instagram:https://www.instagram.com/kidney.healthmd/

LinkedIn: https://www.linkedin.com/in/drbismah/

Website: https://www.drbismah.com/about/

----

Produced by DrTalks: https://drtalks.com/podcast-service/